- Home
- AVXL vs WGO Comparison
AVXL vs WGO Comparison
Compare AVXL & WGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVXL
- WGO
- Stock Information
- Founded
- AVXL 2004
- WGO 1958
- Country
- AVXL United States
- WGO United States
- Employees
- AVXL N/A
- WGO N/A
- Industry
- AVXL Biotechnology: Biological Products (No Diagnostic Substances)
- WGO Homebuilding
- Sector
- AVXL Health Care
- WGO Industrials
- Exchange
- AVXL Nasdaq
- WGO Nasdaq
- Market Cap
- AVXL 956.7M
- WGO 893.6M
- IPO Year
- AVXL N/A
- WGO N/A
- Fundamental
- Price
- AVXL $9.48
- WGO $34.08
- Analyst Decision
- AVXL Strong Buy
- WGO Buy
- Analyst Count
- AVXL 2
- WGO 11
- Target Price
- AVXL $44.00
- WGO $39.60
- AVG Volume (30 Days)
- AVXL 994.2K
- WGO 460.3K
- Earning Date
- AVXL 08-12-2025
- WGO 10-22-2025
- Dividend Yield
- AVXL N/A
- WGO 3.88%
- EPS Growth
- AVXL N/A
- WGO N/A
- EPS
- AVXL N/A
- WGO N/A
- Revenue
- AVXL N/A
- WGO $2,741,800,000.00
- Revenue This Year
- AVXL N/A
- WGO N/A
- Revenue Next Year
- AVXL N/A
- WGO $5.92
- P/E Ratio
- AVXL N/A
- WGO N/A
- Revenue Growth
- AVXL N/A
- WGO N/A
- 52 Week Low
- AVXL $4.93
- WGO $28.00
- 52 Week High
- AVXL $14.44
- WGO $65.65
- Technical
- Relative Strength Index (RSI)
- AVXL 47.45
- WGO 48.18
- Support Level
- AVXL $8.82
- WGO $33.81
- Resistance Level
- AVXL $10.40
- WGO $35.28
- Average True Range (ATR)
- AVXL 0.52
- WGO 1.11
- MACD
- AVXL 0.04
- WGO -0.31
- Stochastic Oscillator
- AVXL 48.68
- WGO 7.75
About AVXL Anavex Life Sciences Corp.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.
About WGO Winnebago Industries Inc.
Winnebago Industries manufactures Class A, B, and C motor homes along with towables, customized specialty vehicles, boats, and parts. Headquartered in Eden Prairie, Minnesota, Winnebago has been producing recreational vehicles since 1958. Revenue was nearly $3 billion in fiscal 2024. Winnebago expanded into towables in 2011 with the acquisition of SunnyBrook and acquired Grand Design in November 2016. Towables made up 83% of the firm's RV unit volume, up from 31% in fiscal 2016. The company's total RV unit volume was 38,796 in fiscal 2024. Winnebago expanded into boating in 2018 with the purchase of Chris-Craft, bought premium motor home maker Newmar in November 2019, and bought Barletta pontoon boats in August 2021. It also is developing electric and autonomous technology.